Patent US4536501A successfully refreshed from Google Patents.
US4536501A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Substituted 4-phenoxy or 4-phenylthio prolines
Assignee: ER Squibb and Sons LLC
•
Filing: 1984-03-30
•
Granted: 1985-08-20
•
Expires: 2004-03-30
Abstract
Abstract Compounds of the formula ##STR1## are disclosed. They possess angiotensin converting enzyme inhibition activity and diuretic activity and are therefore useful as antihypertensive agents.
Inventors
- 👤 Joseph E. Sundeen
- 👤 Rudiger D. Haugwitz
- 👤 Peter W. Sprague
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-09 07:48
CPC Classifications
C; C07; C07D; C07D403/00; C07D403/02; C07D403/12; C07D207/00; C07D207/02; C07D207/04; C07D207/10; C07D207/16; C07D409/00; C07D409/14; C07D417/00; C07D417/02; C07D417/12; C07D417/14; C07F; C07F9/00; C07F9/02; C07F9/547; C07F9/6558; C07F9/65583; C07K; C07K5/00; C07K5/02; C07K5/022; C07K5/0222; A; A61; A61K; A61K38/00
Claims Analysis
Total Claims: 22
Claim 1
Independent Claim
338 words
A compound of the formula ##STR107## and a pharmaceutically acceptable salt thereof wherein X is oxygen or sulfur; --A 1 -A 2 -- is --CH--NH-- or --C═N--; A is ##STR108## p is one, two, three or four; R, R 8 and R 9 are independently selected from the group consisting of hydrogen, lower alkyl, benzyl, benzhydryl, and salt forming ion; R 1 and R 2 are independently selected from the group consisting of hydrogen, halogen, lower alkyl, lower alkoxy, halo substituted lower alkyl, nitro, and --SO 2 NH 2 ; Z is ##STR109## R 3 is hydrogen, lower alkyl, halo substituted lower alkyl, phenyl, benzyl, phenethyl or cycloalkyl; R 4 is hydrogen or ##STR110## R 5 is lower alkyl, ##STR111## n is zero, one, two, three or four; R 6 is hydrogen, lower alkyl, lower alkoxy, halogen, or hydroxy; R 7 is lower alkyl or cycloalkyl; R 10 is hydrogen, lower alkyl, ##STR112## halo substituted lower alkyl, hydroxy substituted lower alkyl, --(CH 2 ) q -cycloalkyl, --(CH 2 ) q -N(lower alkyl) 2 , --(CH 2 ) q --NH 2 , --(CH 2 ) q -carboxy, --(CH 2 ) q --SH, --(CH 2 ) q -S-lower alkyl, ##STR113## q is one, two, three or four; R 11 is hydrogen, lower alkyl, halo substituted lower alkyl, hydroxy substituted lower alkyl, --(CH 2 ) q --NH 2 , --(CH 2 ) q -N(lower alkyl) 2 , --(CH 2 ) q -quanidinyl, ##STR114## R 12 is alkyl of 1 to 10 carbons, ##STR115## cycloalkyl--(CH 2 ) m --; m is zero or an integer from 1 to 7; R 13 is hydrogen, lower alkyl, benzyl, benzhydryl, salt forming ion or ##STR116## R 15 is hydrogen, lower alkyl, cycloalkyl or phenyl; p0 R 16 is hydrogen, lower alkyl, lower alkoxy, cycloalkyl, phenyl, benzyl, or phenethyl; and R 14 is hydrogen, lower alkyl, cycloalkyl-(CH 2 ) n --, ##STR117## halo substituted lower alkyl, hydroxy substituted lower alkyl, --(CH 2 ) q --N(lower alkyl) 2 , or --(CH 2 ) q --NH 2 .
Claim 2
Dependent Claim
338 words
A compound of the formula ##STR107## and a pharmaceutically acceptable salt thereof wherein X is oxygen or sulfur; --A 1 -A 2 -- is --CH--NH-- or --C═N--; A is ##STR108## p is one, two, three or four; R, R 8 and R 9 are independently selected from the group consisting of hydrogen, lower alkyl, benzyl, benzhydryl, and salt forming ion; R 1 and R 2 are independently selected from the group consisting of hydrogen, halogen, lower alkyl, lower alkoxy, halo substituted lower alkyl, nitro, and --SO 2 NH 2 ; Z is ##STR109## R 3 is hydrogen, lower alkyl, halo substituted lower alkyl, phenyl, benzyl, phenethyl or cycloalkyl; R 4 is hydrogen or ##STR110## R 5 is lower alkyl, ##STR111## n is zero, one, two, three or four; R 6 is hydrogen, lower alkyl, lower alkoxy, halogen, or hydroxy; R 7 is lower alkyl or cycloalkyl; R 10 is hydrogen, lower alkyl, ##STR112## halo substituted lower alkyl, hydroxy substituted lower alkyl, --(CH 2 ) q -cycloalkyl, --(CH 2 ) q -N(lower alkyl) 2 , --(CH 2 ) q --NH 2 , --(CH 2 ) q -carboxy, --(CH 2 ) q --SH, --(CH 2 ) q -S-lower alkyl, ##STR113## q is one, two, three or four; R 11 is hydrogen, lower alkyl, halo substituted lower alkyl, hydroxy substituted lower alkyl, --(CH 2 ) q --NH 2 , --(CH 2 ) q -N(lower alkyl) 2 , --(CH 2 ) q -quanidinyl, ##STR114## R 12 is alkyl of 1 to 10 carbons, ##STR115## cycloalkyl--(CH 2 ) m --; m is zero or an integer from 1 to 7; R 13 is hydrogen, lower alkyl, benzyl, benzhydryl, salt forming ion or ##STR116## R 15 is hydrogen, lower alkyl, cycloalkyl or phenyl; p0 R 16 is hydrogen, lower alkyl, lower alkoxy, cycloalkyl, phenyl, benzyl, or phenethyl; and R 14 is hydrogen, lower alkyl, cycloalkyl-(CH 2 ) n --, ##STR117## halo substituted lower alkyl, hydroxy substituted lower alkyl, --(CH 2 ) q --N(lower alkyl) 2 , or --(CH 2 ) q --NH 2 .
Claim 3
Dependent Claim
236 words
A compound of claim 1 of the formula ##STR118## and a pharmaceutically acceptable salt thereof wherein R is hydrogen, lower alkyl of 1 to 4 carbons, or an alkali metal salt ion; R 14 is hydrogen or lower alkyl of 1 to 4 carbons; R 2 is halogen, lower alkyl of 1 to 4 carbons, or halo substituted lower alkyl of 1 to 4 carbons; R 4 is hydrogen or ##STR119## wherein n is zero, one or two; R 3 is lower alkyl of 1 to 4 carbons; R 8 is hydrogen, lower alkyl of 1 to 4 carbons, or an alkali metal salt ion; R 7 is lower alkyl of 1 to 4 carbons; R 9 is hydrogen, lower alkyl of 1 to 4 carbons, or an alkali metal salt ion; R 10 is ##STR120## wherein n is zero, one, two, three or four; R 11 is lower alkyl of 1 to 4 carbons, --CH 2 --S--(CH 2 ) 2 --NH 2 , or --(CH 2 ) 4 --NH 2 ; R 12 is alkyl of 1 to 10 carbons or ##STR121## wherein m is zero or an integer from 1 to 7; R 13 is hydrogen, alkali metal salt ion or ##STR122## R 15 is hydrogen, straight or branched chain lower alkyl of 1 to 4 carbons, or cyclohexyl; and R 16 is straight or branched chain lower alkyl of 1 to 4 carbons.
Claim 4
Dependent Claim
35 words
A compound of claim 2 wherein ##STR123## R 14 is hydrogen or methyl; R 2 is chloro or trifluoromethyl; R 4 is hydrogen or ##STR124## and R is hydrogen or an alkali metal salt ion.
Claim 5
Dependent Claim
22 words
A compound of claim 3 wherein R 4 is ##STR125## R 14 is hydrogen; R 2 is chloro; and R is hydrogen.
Claim 6
Dependent Claim
6 words
The compound of claim 4, (S)-4-[4-[[7-(aminosulfonyl)-6-chloro-3,4-dihydro-1,1-dioxo-2H-1,2,4-benzothiadiazin-3-yl]methyl]phenoxy]-1-[(S)-3-(benzoylthio)-2-methyl-1-oxopropyl]-L-proline.
Claim 7
Dependent Claim
22 words
A compound of claim 3 wherein R 4 is hydrogen; R 14 is hydrogen; R 2 is chloro; and R is hydrogen.
Claim 8
Dependent Claim
6 words
The compound of claim 6, (S)-4-[4-[[7-(aminosulfonyl)-6-chloro-3,4-dihydro-1,1-dioxo-2H-1,2,4-benzothiadiazin-3-yl]methyl]phenoxy]-1-[(S)-3-mercapto-2-methyl-1-oxopropyl]-L-proline.
Claim 9
Dependent Claim
22 words
A compound of claim 3 wherein R 4 is ##STR126## R 14 is hydrogen; R 2 is trifluoromethyl; and R is hydrogen.
Claim 10
Dependent Claim
6 words
The compound of claim 8, (S)-4-[4-[[7-(aminosulfonyl)-3,4-dihydro-1,1-dioxo-6-(trifluoromethyl)-2H-1,2,4-benzothiadiazin-3-yl]methyl]phenoxy]-1-[(S)-3-(benzoylthio)-2-methyl-1-oxopropyl]-L-proline.
Claim 11
Dependent Claim
22 words
A compound of claim 3 wherein R 4 is hydrogen; R 14 is hydrogen; R 2 is trifluoromethyl; and R is hydrogen.
Claim 12
Dependent Claim
6 words
The compound of claim 10, (S)-4-[4-[[7-(aminosulfonyl)-3,4-dihydro-1,1-dioxo-6-(trifluoromethyl)-2H-1,2,4-benzothiadiazin-3-yl]methyl]phenoxy]-1-[(S)-3-mercapto-2-methyl-1-oxopropyl]-L-proline.
Claim 13
Dependent Claim
22 words
A compound of claim 3 wherein R 4 is ##STR127## R 14 is methyl; R 2 is chloro; and R is hydrogen.
Claim 14
Dependent Claim
6 words
The compound of claim 12, (S)-4-[4-[[7-(aminosulfonyl)-6-chloro-3,4-dihydro-2-methyl-1,1-dioxo-2H-1,2,4-benzothiadiazin-3-yl]methyl]phenoxy]-1-[(S)-3-(benzoylthio)-2-methyl-1-oxopropyl]-L-proline.
Claim 15
Dependent Claim
22 words
A compound of claim 3 wherein R 4 is hydrogen; R 14 is methyl; R 2 is chloro; and R is hydrogen.
Claim 16
Dependent Claim
6 words
The compound of claim 14, (S)-4-[4-[[7-(aminosulfonyl)-6-chloro-3,4-dihydro-2-methyl-1,1-dioxo-2H-1,2,4-benzothiadiazin-3-yl]methyl]phenoxy]-1-[(S)-3-mercapto-2-methyl-1-oxopropyl]-L-proline.
Claim 17
Dependent Claim
46 words
A compound of claim 2 wherein A is ##STR128## R 8 is hydrogen, ethyl, or an alkali metal salt ion; R 7 is ethyl; R 14 is hydrogen or methyl; R 2 is chloro or trifluoromethyl; and R is hydrogen or an alkali metal salt ion.
Claim 18
Dependent Claim
50 words
A compound of claim 2 wherein A is ##STR129## R 9 is hydrogen, ethyl, or an alkali metal salt ion; R 10 is ##STR130## R 11 is methyl; R 14 is hydrogen or methyl; R 2 is chloro or trifluoromethyl; and R is hydrogen or an alkali metal salt ion.
Claim 19
Dependent Claim
76 words
A compound of claim 2 wherein A is ##STR131## R 12 is ##STR132## R 13 is hydrogen, alkali metal salt ion, or ##STR133## R 15 is hydrogen, straight or branched chain lower alkyl of 1 to 4 carbons, or cyclohexyl; R 16 is straight or branched chain lower alkyl of 1 to 4 carbons; R 14 is hydrogen or methyl; R 2 is chloro or trifluoromethyl; and R is hydrogen or an alkali metal salt ion.
Claim 20
Dependent Claim
55 words
A composition useful for treating hypertension comprising a pharmaceutically acceptable carrier and an effective amount of a hypotensive agent or pharmaceutically acceptable salt thereof of the formula ##STR134## wherein A, --A 1 -A 2 --, R, R 1 , R 2 , R 14 , p, X, and Z are as defined in claim 1.
Claim 21
Dependent Claim
21 words
The method of treating hypertension in a mammalian specie which comprises administering an effective amount of the composition of claim 19.
Claim 22
Dependent Claim
32 words
A compound of the formula ##STR135## wherein --A 1 -A 2 --, p, R, R 1 , R 2 , R 14 , X and Z are as defined in claim 1.
References Cited (Backward Citations)
AU13837A
Cited
JPS5151555A
Cited
US4105776A
Cited
US4217347A
Cited
US4316906A
Cited
BE879158A
Cited
US4168267A
Cited
US4374829A
Cited
EP0018549A2
Cited
US4337201A
Cited
US4431644A
Cited
US4431645A
Cited
EP0088350B1
Cited
EP0095584A2
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1988-08-19 | 1989-02-18 | 1989-08-20 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1992-08-19 | 1993-02-18 | 1993-08-20 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1996-08-19 | 1997-02-18 | 1997-08-20 | $7700.00 | Window Closed / Lapsed |